The global infection control market is expected to grow at a CAGR of ~3.3% from 2021 to reach ~54.8 billion by 2027. The growth is primarily attributed to prevalence of infectious diseases, rising geriatric population, rising focus on sterilization, technological advancements, expansion of pharmaceutical companies and medical devices in emerging economies, increasing number of surgical procedures and rising outsourcing of sterilization services. However, safety aspect of reprocessed instruments can hinder the growth of this market. COVID-19 has offered significant growth opportunity to the market players.
By Product & Services: Protective barrier segment dominated the infection control market in 2020
Based on products & services, infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprossing products and other infection control products. Protective barrier segment accounted for the largest share of infection control market. The largest share of this market is mainly due to significant rise adoption of medical non-woven such as masks, gowns, and face masks due to COVID-19 pandemic.
By End User: The hospitals & clinics segment accounted for largest share in 2020
On the basis of end user, infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, life science industry, food industry and other end users. Hospitals & clinics segment accounted for largest market share of infection control market in 2020. The largest share of this market segment can be attributed to supportive government initiatives, prevalence of infectious diseases, rising number of hospitals & clinics, and growing geriatric population. However, increasing number of COVID-19 has also increased the adoption of sterilization and disinfectants in the hospitals.
By Region: APAC fastest growing regional market while North America maintains the lead
In 2020, North America accounted for largest share of Infection control market. The largest share of this regional segment can be attributed to rising geriatric population, prevalence of chronic diseases, favorable government initiatives, stringent regulation on sterilization, increasing focus on healthy lifestyle and growing demand for adoption of sterilization products. APAC is expected to grow at highest CAGR during the forecast period. High growth of this geographic segment is mainly attributed to outsourcing of sterilization services in emerging economies such as India, China, rising awareness towards spread of infections and measures of prevention of infections.
Competitive Scenario
Some of the key players operating in this market are
- Getinge AB (Sweden)
- STERIS plc. (US)
- Advanced Sterilization Products (US)
- 3M Company (US)
- Belimed AG (Switzerland)
- Cantel Medical Corporation (US)
- MMM Group (Germany)
- MATACHANA GROUP (Spain)
- Sotera Health LLC (US)
- Ecolab, Inc. (US)
- Metrex Research Corporation (US)
- Reckitt Benckiser Group Plc. (UK)
- Miele Group (Germany)
- Melag (Germany)
- Pal International (UK)
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Infection Control Market
4.4. Market Trends
5. Global Infection Control Market, By Service Type, 2019-2027 (USD Million)
5.1. Sterilization Products and Services
5.1.1. Sterilization Equipment
5.1.1.1. Heat Sterilization Equipment
5.1.1.1..1. Moist Heat Sterilizers
5.1.1.1..2. Dry Heat Sterilizers
5.1.1.2. Low-Temperature Sterilization
5.1.1.2..1. Hydrogen Peroxide Sterilization
5.1.1.2..2. Ethylene Oxide Sterilization (ETO)
5.1.1.2..3. Formaldehyde Sterilization
5.1.1.2..4. Other Low-Temperature Sterilization
5.1.1.3. Radiation Sterilization
5.1.1.4. Filtration Sterilization
5.1.1.5. Other Equipment
5.1.2. Contract Sterilization Services Market
5.1.2.1. ETO Sterilization Services
5.1.2.2. Gamma Sterilization Services
5.1.2.3. E-Beam Sterilization Services
5.1.2.4. Steam Sterilization Services
5.1.2.5. Other Sterilization Services
5.1.3. Consumables and Accessories
5.1.3.1. Sterilization Indicators
5.1.3.1..1. Chemical Indicators
5.1.3.1..2. Biological Indicators
5.1.3.2. Packaging Accessories
5.2. Cleaning and Disinfection Products
5.2.1. Disinfectants
5.2.1.1. Disinfectants, By Product Type
5.2.1.1..1. Hand Disinfectants
5.2.1.1..2. Surface Disinfectants
5.2.1.1..3. Skin Disinfectants
5.2.1.1..4. Instrument Disinfectants
5.2.1.2. Disinfectants, By Formulation
5.2.1.2..1. Disinfectant Wipes
5.2.1.2..2. Liquid Disinfectants
5.2.1.2..3. Disinfectant Sprays
5.2.1.3. Disinfectants, By EPA Classification
5.2.1.3..1. Low-Level Disinfectants
5.2.1.3..2. Intermediate-Level Disinfectants
5.2.1.3..3. High-Level Disinfectants
5.2.2. Cleaning and Disinfection Equipment
5.2.2.1. Washer Disinfectors
5.2.2.2. Flusher Disinfectors
5.2.2.3. UV-Ray Disinfectors
5.2.2.4. Ultrasonic Cleaners
5.2.2.5. Other Cleaning and Disinfection Equipment
5.2.3. Lubricants and Cleaning Solutions
5.2.4. Disinfection and Cleaning Accessories
5.3. Protective Barriers
5.3.1. Medical Nonwovens
5.3.1.1. Surgical Drapes
5.3.1.2. Surgical Gowns
5.3.1.3. Face Masks
5.3.2. Covers and Closures
5.3.3. Goggles
5.3.4. Gloves
5.4. Endoscope Reprocessing Products
5.4.1. Endoscope Reprocessing Consumables
5.4.2. Endoscope Reprocessing Equipment
5.4.2.1. Automated Endoscope Reprocessors
5.4.2.2. Endoscope Tracking Systems
5.4.3. Other Endoscope Reprocessing Products
5.5. Other Infection Control Products
6. Global Infection Control Market, By End User, 2019-2027 (USD Million)
6.1. Hospital & Clinics
6.2. Medical Device Companies
6.3. Pharmaceutical Companies
6.4. Life Science Industry
6.5. Food Industry
6.6. Other End Users
7. Global Infection Control Market, By Geography, 2019-2027 (USD Million)
7.1. North America
7.1.1. US
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. UK
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Rest of Asia-Pacific
7.4. Rest of the World
7.4.1. Latin America
7.4.2. Middle East & Africa
8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis, By Key Players (2020)
8.3. Competitive Scenario
8.3.1. Product Launches
8.3.2. Partnerships, Collaborations and Agreements
8.3.3. Acquisitions
8.3.4. Expansions
8.3.5. Other Developments
9. Company Profiles
9.1. Getinge AB (Sweden)
9.2. STERIS plc. (US)
9.3. Advanced Sterilization Products (US)
9.4. 3M Company (US)
9.5. Belimed AG (Switzerland)
9.6. Cantel Medical Corporation (US)
9.7. MMM Group (Germany)
9.8. MATACHANA GROUP (Spain)
9.9. Sotera Health LLC (US)
9.10. Ecolab, Inc. (US)
9.11. Metrex Research Corporation (US)
9.12. Reckitt Benckiser Group Plc. (UK)
9.13. Miele Group (Germany)
9.14. Melag (Germany)
9.15. Pal International (UK)
10. Appendix
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
